Randomized Trial of Tenecteplase to Treat Severe Submassive Pulmonary Embolism
Phase of Trial: Phase III
Latest Information Update: 14 Aug 2013
At a glance
- Drugs Tenecteplase (Primary) ; Enoxaparin sodium
- Indications Pulmonary embolism
- Focus Adverse reactions
- 31 Aug 2018 Biomarkers information updated
- 10 Mar 2013 Results presented at the 62nd Annual Scientific Session of the American College of Cardiology.
- 10 Mar 2013 Status changed from recruiting to completed.